Embl Ventures

About The Fund

EMBL Ventures is a venture capital firm focused on nurturing growth and innovation in the biotechnology, medical technology, and life science sectors. With their base in Heidelberg, Germany, EMBL Ventures primarily targets investment opportunities throughout Europe. Their investment thesis is centered on the creation and support of companies that generate significant commercial opportunities derived from new therapeutic treatment modalities, pharmaceutical innovations, as well as advancements in diagnostics and medical device technologies. EMBL Ventures possesses a profound scientific and industry-specific network, which, combined with their solid investment history, provides a robust foundation for company building. This network also ensures that portfolio companies gain access to a unique ecosystem, which includes the European Molecular Biology Laboratory (EMBL). Their team is well-versed in the life science industry with hands-on experience in forming successful companies as well as expertise in finalizing collaboration and licensing deals, mergers and acquisitions, and orchestrating initial public offerings. EMBL Ventures firmly believes in offering engaged companies the individual time and attention they need to thrive, maximizing their chances for success. The companies that partner with EMBL Ventures not only benefit from direct support from the firm's experienced team but also from the unique access to resources offered by the EMBL, which adds substantial value to their growth journey.